主动脉瓣置换装置市场战略、顶尖企业、增长机会、2030 年分析及预测

  • Report Code : TIPRE00002871
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 165
Buy Now

Aortic Valve Replacement Devices Market Report | 2022-2030

Buy Now

 

[研究报告] 2022 年主动脉瓣置换装置市场价值为 71.1339 亿美元,预计到 2030 年将达到 180.7032 亿美元。预计 2022-2030 年期间的复合年增长率为 12.4%。  

 

分析师观点

主动脉瓣置换装置市场分析解释了驱动因素,例如主动脉瓣置换手术数量的增加和对微创技术的需求不断增加。此外,临床研究数量的增加是 2022-2030 年市场增长的未来趋势。2022 年,无缝线瓣膜部分占主动脉瓣置换装置市场的较大份额(按产品计算)。就手术而言,微创手术部分在 2022 年占据了市场主导地位。按最终用户划分,医院和诊所部分将在预测期内以相当大的份额主导主动脉瓣置换装置市场。

主动脉瓣是调节心脏血流的四个瓣膜之一。主动脉瓣将心脏的主要泵血腔与向身体供应富氧血液的主动脉隔开。主动脉瓣修复或主动脉瓣置换可治疗主动脉瓣疾病,帮助恢复正常血流、减轻症状、延长寿命并帮助维持心肌功能。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

主动脉瓣置换装置市场:

主动脉瓣置换装置市场
  • Aortic Valve Replacement Devices Market
    复合年增长率(2022 - 2030 年)
    12.4%
  • 2022 年市场规模
    71.1 亿美元
  • 2030 年市场规模
    180.7 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 雅培实验室
  • 美敦力公司
  • 波士顿科学公司
  • 利瓦诺瓦股份有限公司
  • 爱德华生命科学公司
  • Braile Biomedica 工业、商业和代表有限公司
  • 亚特维昂公司
  • JenaValve 技术公司
  • 杭州启明医疗科技有限公司

区域概况

Aortic Valve Replacement Devices Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Aortic Valve Replacement Devices Market产品
  • 无缝线瓣膜和机械瓣膜
Aortic Valve Replacement Devices Market外科手术
  • 微创手术和开放手术
Aortic Valve Replacement Devices Market最终用户
  • 医院和诊所
  • 门诊手术中心
  • 其他的
Aortic Valve Replacement Devices Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场洞察

 

主动脉瓣置换手术数量的增加推动了主动脉瓣置换装置市场的增长

近期,全球范围内主动脉瓣置换手术的数量显著增加。根据德克萨斯赫拉特研究所发布的数据,美国每年约有 106,000 例心脏瓣膜手术。几乎所有手术中都会修复或更换二尖瓣或主动脉瓣。这种激增可归因于多种因素,包括医疗技术的进步、人口老龄化以及对心脏相关疾病认识的提高。主动脉瓣置换术是一种关键手术,通常用于治疗主动脉瓣狭窄或反流——如果不及时治疗,可能会导致严重的并发症。随着医学科学的不断发展,这些手术有望变得更加安全和更容易获得,有助于改善患者的治疗效果并提高主动脉瓣疾病患者的生活质量。医疗保健系统正在适应对外科手术日益增长的需求,强调预防措施和早期发现对管理心血管健康的重要性。

 

技术进步为主动脉瓣置换装置市场创造丰厚机会

微创手术技术 (MIS) 的发展,例如经导管主动脉瓣置换术 (TAVR),使主动脉瓣狭窄 (AS) 的治疗现代化。经导管手术,例如经导管主动脉瓣置换术 (TAVR),使主动脉瓣狭窄 (AS) 的治疗现代化。经导管主动脉瓣置换术比传统的开胸手术创伤更小,使原本可能不适合手术的高危患者也能够接受治疗。此外,材料和设计的发展促进了更坚固、生物相容的主动脉瓣置换术的发展,从而改善了患者的治疗效果并降低了并发症的风险。

下面提到了主动脉瓣置换装置领域参与者的一些技术进步:

  • 2023 年 1 月,雅培获得 FDA 批准使用 Navitor 经导管主动脉瓣植入 (TAVI) 系统,用于治疗患有严重主动脉瓣狭窄且需要开胸手术的患者。Navitor 是该公司广泛的经导管结构性心脏产品组合的最新成员,该产品组合为医生和患者提供了针对一系列严重心脏病的微创治疗选择。
  • 2022 年 9 月,美敦力宣布在美国扩展其最新一代自膨胀 TAVR 系统——Evolut FX TAVR 系统。Evolut FX 为现有的 Evolut 平台添加了新功能,以提高医生的易用性和可预测的瓣膜部署。
  • 2022 年 9 月,Edwards Lifesciences 推出了 SAPIEN 3 Ultra RESILIA 瓣膜,该瓣膜结合了 Edwards 突破性的 RESILIA 组织技术和业界领先的 SAPIEN 3 Ultra 经导管主动脉心脏瓣膜。该产品最近已获得美国食品药品监督管理局 (FDA) 的批准。
  • 2021 年 9 月,雅培的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜获得 FDA 批准,用于改善主动脉瓣或二尖瓣疾病患者的治疗选择。凭借这款新设备,雅培扩展了其 Epic 手术瓣膜平台。
  • 2021 年 8 月,CORCYM 在现实世界环境中招募了首位二尖瓣、主动脉瓣和三尖瓣上市后研究患者,即 MANTRA。首例植入是在意大利 Citta di Lecce 医院进行的,植入的是 Bicarbon 主动脉机械瓣膜。
  • 2021年8月,印度首例3D打印心脏瓣膜在钦奈研发成功。新型心脏瓣膜采用3D打印机研发,可克服人工心脏瓣膜相关问题。
  • 2020年9月,波士顿科学公司在欧洲推出了ACURATE neo2主动脉瓣系统。这项新一代TAVI技术是一个新平台,具有多种功能,旨在改善原有ACURATE neo平台的临床性能。与上一代主动脉瓣系统相比,它扩大了对主动脉瓣狭窄患者的适应症。

因此,技术进步正在为主动脉瓣置换装置市场创造丰厚的机会。

 

报告细分和范围

 

基于产品的见解

根据产品,主动脉瓣置换装置市场分为机械瓣膜和无缝线瓣膜。无缝线瓣膜部分在 2022 年占据了较大的市场份额,并且很可能在 2022-2030 年期间在主动脉瓣置换装置市场中实现显着的复合年增长率。无缝线主动脉瓣置换装置是一种生物瓣膜,设计用于实施而无需传统缝合,而传统缝合是将瓣膜固定到位所必需的。这些瓣膜通常由生物材料制成。瓣膜连接到支架或框架上,一旦将其正确放置在患者的原生主动脉瓣环内,支架或框架就可以扩张并固定到位。无缝线主动脉瓣的主要优点是它们可以简化手术程序,减少手术时间并可能改善结果,尤其是对于风险较高或由于其他医疗条件而无法进行手术的患者。与任何医疗程序一样,主动脉瓣置换装置(包括无缝线瓣膜)的选择取决于患者的具体状况、整体健康状况和个体风险因素。

 

基于手术的见解

根据手术,主动脉瓣置换装置市场分为开放手术和微创手术。微创手术部分在 2022 年占据了更大的市场份额,预计在 2022-2030 年期间的复合年增长率会更高。与传统的开放手术相比,主动脉瓣置换的微创手术是一种侵入性较小的方法。它涉及进行较小的切口,通常使用专门的手术器械和视频辅助技术,以进入心脏,用人工瓣膜(机械瓣膜或生物瓣膜)替换功能不佳的主动脉瓣。微创技术的潜在好处包括住院时间更短、疤痕更少、恢复时间更快(在正常情况下)。在大多数情况下,选择 TAVR 手术是因为它们对组织造成的损伤更小,并且恢复时间更快。根据《新英格兰医学杂志》的报道,自 2007 年这项技术问世以来,TAVR 手术的数量显着增加,因为手术置换已被证明不适合老年患者。随着医疗技术的进步,这些微创方法为需要进行主动脉瓣置换的患者提供了更多选择和更好的治疗效果。

 

基于最终用户的洞察

就最终用户而言,主动脉瓣置换装置市场细分为医院和诊所、门诊手术中心和其他。医院和诊所部门在 2022 年占据了最大的市场份额。医院和诊所是主动脉瓣置换装置的最大最终用户,可用于治疗不同年龄段、患有各种疾病的患者。许多患者到医院寻求治疗他们的急性和慢性疾病。医院的医务人员为患者提供便捷的服务和最好的护理。因此,医院的目标是恢复和维护公众的健康。在医院工作的工作人员了解不同的主动脉瓣置换装置。慢性病患病率的上升、老年人口的增加以及医院数量的增加主要促进了医院部门主动脉瓣置换市场的增长。老年人住院的可能性是中年成年人的两倍;大约 17% 的 65 岁及以上美国人每年至少住院一次,而 45-64 岁的成年人中只有 8% 需要住院。心血管疾病、癌症、中风和神经系统疾病是老年患者住院的主要原因。因此,在预测期内,住院患者人数的增加可能会推动医院市场的增长。

 

区域分析

2022 年,北美占据了主动脉瓣置换装置市场的主导地位,占据了最大份额,其中美国、加拿大和墨西哥是该地区市场增长的主要贡献者。美国是该地区最大的主动脉瓣置换装置市场。北美主动脉瓣置换装置市场的增长归因于心脏病患病率的上升以及监管批准、研发活动和新产品发布的增加。此外,产品技术的进步可能会为该地区的主动脉瓣置换装置市场提供增长机会。

根据克利夫兰诊所的数据,心脏瓣膜疾病影响美国约 2.5% 的人。这些包括瓣膜反流(漏水)或狭窄(变窄)。二尖瓣反流和主动脉瓣狭窄是美国最常见的瓣膜疾病。美国有超过 200 万人患有心脏瓣膜漏水。美国是北美主动脉瓣置换装置市场的前列。在美国,近 150 万人患有主动脉瓣狭窄。根据美国国立卫生研究院 (NIH) 发布的数据,2021 年,该国每年进行约 78,000 例经导管主动脉瓣植入 (TAVI) 手术。关键参与者的存在和该地区临床研究数量的增加推动了市场增长。私人机构采取的举措也有望促进市场的增长。例如,爱德华生命科学基金会正在赞助美国心脏协会在美国的瓣膜疾病教育中心和大使计划。因此,上述因素预计将推动美国市场的增长。

报告介绍了全球主动脉瓣置换设备市场的领先企业。这些企业包括 Virgin Pulse Inc、Limeade Inc、Optum Inc、Vitality Group International Inc、Bravo Wellness LLC、Sonic Boom Wellness LLC、WebMD Health Services Group Inc、Fitbit LLC、Asset Health Inc、Healthcheck360、Marquee Health LLC、Wellright Inc、Wellworks for You、Wellable LLC、Wellness 360 Technologies Inc、WellSteps.com LLC 和 CHC Wellbeing Inc。

  • 2023 年 2 月,美敦力重新推出了其 Harmony 经导管肺动脉瓣 (TPV) 系统,这是针对具有原生或手术修复的右心室流出道 (RVOT) 的先天性心脏病患者的开胸手术的微创替代方案。
  • 2023 年 1 月,雅培公司获得美国食品药品监督管理局 (FDA) 批准,使用该公司最新一代经导管主动脉瓣植入 (TAVI) 系统 Navitor,用于治疗严重主动脉瓣狭窄且开胸手术风险高或极高的患者。Navitor TAVI 系统是该公司全面的经导管结构性心脏产品组合的最新成员,可为医生和患者提供一些最常见和最严重的心脏病的微创治疗选择。
  • 2021 年 7 月,Limeade 收购了员工聆听软件领域的先驱 TINYPULSE。此次收购将使两家致力于帮助客户创造健康员工体验的公司联合起来。
  • 2021 年 11 月,Virgin Pulse 收购了 Welltok,以推动改善健康结果并降低成本。此次收购将使两家公司推出业界首个端到端参与和激活平台,为整个健康社区的客户、会员和消费者提供支持。

 

主动脉瓣置换装置市场报告范围

报告属性细节
2022 年市场规模71.1亿美元
2030 年的市场规模180.7 亿美元
全球复合年增长率(2022 - 2030 年)12.4%
历史数据2020-2021
预测期2023-2030
涵盖的领域按产品
  • 无缝线瓣膜和机械瓣膜
通过手术
  • 微创手术和开放手术
按最终用户
  • 医院和诊所
  • 门诊手术中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 雅培实验室
  • 美敦力公司
  • 波士顿科学公司
  • 利瓦诺瓦股份有限公司
  • 爱德华生命科学公司
  • Braile Biomedica 工业、商业和代表有限公司
  • 亚特维昂公司
  • JenaValve 技术公司
  • 杭州启明医疗科技有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

公司简介

 

  • 雅培实验室
  • 美敦力公司
  • 波士顿科学公司
  • 利瓦诺瓦股份有限公司
  • 爱德华生命科学公司
  • Braile Biomedica 工业、商业和代表有限公司
  • 亚特维昂公司
  • 耶拿阀门科技公司
  • 杭州启明医疗科技有限公司
  • Labcor实验室有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the aortic valve replacement devices market?

The aortic valve replacement devices market majorly consists of the following players, Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, JenaValve Technology Inc, Venus MedTech HangZhou Inc, and Labcor Laboratorios Ltda.

Which segment is dominating the aortic valve replacement devices market?

Based on product, the aortic valve replacement devices market is bifurcated into mechanical valve and sutureless valve. The sutureless valve segment held the larger market share in 2022 and the same segment registered a significant CAGR in the aortic valve replacement devices market in 2022-2030.

What are the driving factors for the aortic valve replacement devices market?

The factors driving the growth of the aortic valve replacement devices market include the rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques. However, the product recalls of aortic valve replacement devices hampers the growth of the aortic valve replacement devices market.

What is aortic valve replacement devices?

Aortic valve repair and aortic valve replacement are methods that treat diseases affecting the aortic valve. The aortic valve is one of four valves that regulate blood flow through the heart. The aortic valve separates the heart's main pumping chamber and the main artery that supplies oxygen-rich blood to body. Aortic valve repair or aortic valve replacement treats aortic valve disease and help restore normal blood flow, reduces symptom, prolong life and help preserves the function of the heart muscle.

What are the growth estimates for the aortic valve replacement devices market till 2030?

The aortic valve replacement devices market is expected to be valued at US$ 18,070.32 billion in 2030.

What was the estimated aortic valve replacement devices market size in 2022?

The aortic valve replacement devices market was valued at US$ 7,113.39 billion in 2022.

The List of Companies - Aortic Valve Replacement Devices Market

  1. Abbott Laboratories
  2. Medtronic Plc
  3. Boston Scientific Corp
  4. LivaNova Plc
  5. Edwards Lifesciences Corp
  6. Braile Biomedica Industry, Commerce and Representations Ltd
  7. Artivion Inc
  8. JenaValve Technology Inc.
  9. Venus MedTech HangZhou Inc.
  10. Labcor Laboratorios Ltda

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..